Mitochondrial InjuryLessons from the Fialuridine Trial

被引：0
|
作者：
Pieter Honkoop
Hans R. Scholte
Robert A. de Man
Solko W. Schalm
机构：
[1] Erasmus University Hospital,Department of Internal Medicine II (Section Hepatology)
[2] Erasmus University Hospital,Department of Biochemistry
[3] Erasmus University Hospital,Department of Internal Medicine II (Ca 326)
来源：
Drug Safety | 1997年 / 17卷
关键词：
Chronic Hepatitis; Lamivudine; Zidovudine; Lactic Acidosis; Nucleoside Analogue;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Fialuridine is an antiviral agent with potent activity against hepatitis B virus replication in vitro and in vivo. In a phase II study, 7 of 15 patients experienced severe toxicity due to the drug after 9 to 13 weeks of treatment. Adverse effects included nausea, vomiting and painful paraesthesia; subsequently, hepatic failure, pancreatitis, neuropathy, myopathy and lactic acidosis developed, probably due to multisystem mitochondrial toxicity.
引用
收藏
页码：1 / 7
页数：6
相关论文
共 50 条
  • [1] Mitochondrial injury - Lessons from the fialuridine trial
    Honkoop, P
    Scholte, HR
    deMan, RA
    Schalm, SW
    DRUG SAFETY, 1997, 17 (01) : 1 - 7
  • [2] Lessons from the fialuridine trial
    Reactions Weekly, 1997, 661 (1) : 3 - 3
  • [3] DEATHS IN US FIALURIDINE TRIAL
    BRAHAMS, D
    LANCET, 1994, 343 (8911): : 1494 - 1495
  • [4] Mitochondrial and cellular toxicity induced by fialuridine in human muscle in vitro
    SeminoMora, C
    LeonMonzon, M
    Dalakas, MC
    LABORATORY INVESTIGATION, 1997, 76 (04) : 487 - 495
  • [5] Fialuridine (FIAU) treatment decreases abundance of mitochondrial (mt-) DNA in vivo
    Lewis, W
    Griniuviene, B
    Ascenzi, MA
    Tennant, BC
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (03) : A197 - A197
  • [6] Targeting Progressive Neuroaxonal InjuryLessons from Multiple Sclerosis
    Amit Bar-Or
    Peter Rieckmann
    Anthony Traboulsee
    V. Wee Yong
    CNS Drugs, 2011, 25 : 783 - 799
  • [7] Clinical Trial Safety Surveillance in the New Regulatory and Harmonization Environment: Lessons Learned from the “Fialuridine Crisis”
    James Nickas
    Drug information journal : DIJ / Drug Information Association, 1997, 31 (1): : 63 - 70
  • [8] Depletion of mitochondrial DNA, destruction of mitochondria, and accumulation of lipid droplets result from fialuridine treatment in woodchucks (Marmota monax)
    Lewis, W
    Griniuviene, B
    Tankersley, KO
    Levine, ES
    Montione, R
    Engelman, L
    deCourtenMyers, G
    Ascenzi, MA
    Hornbuckle, WE
    Gerin, JL
    Tennant, BC
    LABORATORY INVESTIGATION, 1997, 76 (01) : 77 - 87
  • [9] Mechanisms for the anti-hepatitis B virus activity and mitochondrial toxicity of fialuridine (FIAU)
    Colacino, JM
    ANTIVIRAL RESEARCH, 1996, 29 (2-3) : 125 - 139
  • [10] Incorporation of fialuridine (FIAU) into mitochondrial DNA and effects of FIAU on the morphology of mitochondria in human hepatoblastoma cells
    Colacino, JM
    Horn, JW
    Horn, DM
    Richardson, FC
    TOXICOLOGY IN VITRO, 1996, 10 (03) : 297 - 303
12345